nt-ko-003
Small moleculeexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2011 (NCT01428726)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- nt-ko-003
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01428726 | Phase 2 | Jun 1, 2011 | Advancell - Advanced In Vitro Cell Technologies, S.A., Neurotec Pharma, University of Barcelona |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Advancell - Advanced In Vitro Cell Technologies, S.A. | For profit | 1 | 0 | 1 | 2011 |
| Neurotec Pharma | For profit | 1 | 1 | 1 | 2011 |
| University of Barcelona | Academic/Hospital | 1 | 0 | 1 | 2011 |
3 organizations
Page 1 / 1